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SUMMARY
The creation of translation-competent mRNA is
dependent on RNA polymerase II transcripts being
modified by addition of the 7-methylguanosine
(m7G) cap. The factors that mediate splicing, nuclear
export, and translation initiation are recruited to the
transcript via the cap. The cap structure is formed
by several activities and completed by RNMT (RNA
guanine-7 methyltransferase), which catalyzes N7
methylation of the cap guanosine. We report that
CDK1-cyclin B1phosphorylates theRNMT regulatory
domain on T77 during G2/M phase of the cell cycle.
RNMT T77 phosphorylation activates the enzyme
both directly and indirectly by inhibiting interaction
with KPNA2, an RNMT inhibitor. RNMT T77 phos-
phorylation results in elevated m7G cap methyltrans-
ferase activity at the beginning of G1 phase, coordi-
nating mRNA capping with the burst of transcription
that occurs following nuclear envelope reforma-
tion. RNMT T77 phosphorylation is required for the
production of cohort of proteins, and inhibiting T77
phosphorylation reduces the cell proliferation rate.
INTRODUCTION
Maturation of RNA polymerase (pol) II transcripts into translation-
competent mRNA is dependent on addition of the 7-methylgua-
nosine (m7G) cap to the first transcribed nucleotide (Shuman,
2015; Topisirovic et al., 2011). The resultant m7G cap protects
transcripts from exonucleases and is a docking site for the cap
binding complex (CBC), eukaryotic initiation factor 4F (eIF4F),
and other complexes that mediate transcript splicing, polyade-
nylation, nuclear export, and translation initiation (Gonatopou-
los-Pournatzis and Cowling, 2014; Topisirovic et al., 2011). The
enzymes that catalyze m7G synthesis can also promote tran-
scription by direct interactionswith RNApol II-associated factors
(Buratowski, 2009; Perales and Bentley, 2009).
mRNA capping occurs during the early stages of transcrip-
tion, allowing the cap structure to coordinate almost all mRNA
processing events. RNA is synthesized with a 50 triphosphate
group on the first transcribed nucleotide on which the cap is
formed by the sequential action of a triphosphatase, guanylyl-
transferase, andmethyltransferase (Shuman, 2015). In mammals,
RNA guanylyltransferase and 50 triphosphatase (RNGTT) contains
the triphosphatase and guanylyltransferase activities. Themethyl-
transferase activity resides in a separate complex, RNMT-RAM,
which consists of a catalytic subunit, RNA guanine-7methyltrans-
ferase (RNMT), and an activating subunit, RNMT-activating mini-
protein (RAM) (Gonatopoulos-Pournatzis et al., 2011; Pillutla
et al., 1998; Tsukamoto et al., 1998). RNMT contains a regulatory
domain that affects catalytic activity and recruits RNMT-RAM to
transcription initiation sites (Aregger and Cowling, 2013).
Co-transcriptional capping is facilitated by the recruitment of
the capping enzymes to the phosphorylated RNA pol II C-termi-
nal domain (CTD) during the early stages of transcription (Bura-
towski, 2009; Nilson et al., 2015; Perales and Bentley, 2009).
RNGTT is activated by direct interaction with phosphorylated
RNA pol II (Ghosh et al., 2011) and elongation factor Spt5 (Wen
and Shatkin, 1999). RNMT-RAM is also recruited to RNA pol II
in a phosphorylation-dependent manner, although the interac-
tion is unlikely to be direct because it cannot be observed with
purified proteins in vitro (Aregger and Cowling, 2012, 2013).
RNMT has been observed to be activated by interaction with
Importin a-1 (KPNA2) (Wen and Shatkin, 2000).
The mRNA cap is a potent modification, and its regulation has
significant effects on gene expression and cell physiology. In
mammals, formation of the mRNA cap is regulated by c-Myc,
a transcription factor oncogene that promotes deregulated cell
proliferation in many human tumor types. Regulated capping is
critical for c-Myc-dependent protein synthesis, cell proliferation,
and transformation. c-Myc increases promoter recruitment of
the kinase transcription factor II H (TFIIH), resulting in increased
RNA pol II phosphorylation, which increases recruitment of the
capping enzymes and elevated mRNA cap methylation (Aregger
and Cowling, 2012; Cole and Cowling, 2009; Cowling and Cole,
2007). c-Myc also upregulates S-adenosyl homocysteine hydro-
lase (SAAH), which hydrolyses the repressive methylation by-
product S-adenosyl homocysteine (SAH) (Fernandez-Sanchez
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Figure 1. RNMT Is Phosphorylated on T77
(A) HA-RNMT-expressing 293 cells were cultured with 32P orthophosphate, HA-RNMT-immunoprecipitated via an HA tag, and resolved by SDS-PAGE, and
proteins were detected by phosphoimaging (phos) and western blot (WB). vec, vector.
(B) Cells were transfected with RNMT or control (con) siRNA for 48 hr and then cultured with 32P orthophosphate. Endogenous RNMT IP was performed using
anti-RNMT antibodies, and protein was detected. Anti-GST antibodies were used as a control.
(C) A phosphorylated RNMT peptide was identified in HA-RNMT by LC-MS/MS precursor ion scan. Potential phosphorylated amino acids are underlined. Mascot
score (MS) and expected value (Exp) are indicated.
(D) HeLa cells expressing HA-RNMT WT, T77A-S79A, T77A, and S79A were cultured with 32P orthophosphate and analyzed as in (A). Phospho-RNMT in two
independent experiments was quantified relative to RNMT WT. Average and SD are depicted.
(E) WBs were performed to detect pT77 and total RNMT in HA-RNMT WT and T77A immunoprecipitates with (+PI) and without (PI) phosphatase inhibitors.
(legend continued on next page)
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et al., 2009). Another transcription factor, E2F1, has been found
to promote RNA pol II phosphorylation and cap formation (Are-
gger and Cowling, 2012). Regulation of mRNA capping is also
observed in yeast. Amino acid or glucose starvation reduces
mRNA cap methylation (Jiao et al., 2010).
In this study we investigated whether signaling pathways
that result in post-translational modification of the capping en-
zymes can directly regulate their activity. We report that RNMT
is phosphorylated and activated by CDK1-cyclin B1, resulting
in elevated cap methyltransferase activity when transcription is
reinitiating after mitosis. RNMT phosphorylation is rate-limiting
for gene expression and cell proliferation.
RESULTS
RNMT Is Phosphorylated on T77
To investigate RNMT phosphorylation, HEK293 cells expressing
hemagglutinin (HA)-RNMT or vector control were cultured in 32P
orthophosphate, which is incorporated into cellular proteins. HA-
RNMT was immunoprecipitated from cell extracts and resolved
by gel electrophoresis, and a 65-kDa band consistent with the
size of RNMT was detected by phosphoimaging, confirming
phosphorylation of RNMT (Figure 1A). Endogenous RNMT phos-
phorylation was observed by the same methodology, the signal
for which was reduced following transfection with RNMT small
interfering RNA (siRNA) (Figure 1B). Mass spectrometric analysis
of HA-RNMT purified from HeLa cells identified a peptide with
one phosphorylated residue, on either RNMT T77 or S79 (Fig-
ure 1C). To discern the predominant site of phosphorylation,
HeLa cells expressing HA-RNMT wild-type (WT), T77A, S79A,
or T77A-S79A were incubated in 32P orthophosphate, and label
incorporation was determined (Figure 1D). Quantitation of two in-
dependent experiments indicated that the T77A-S79A mutation
resulted in a 74% reduction in phosphorylation, whereas the
T77A and S79A mutations resulted in 63% and 46% reduction
in phosphorylation, respectively (Figure 1D). Therefore, the pre-
dominant site of RNMT phosphorylation in HeLa cells is T77.
S79 may be phosphorylated less than T77 and/or may form
part of the T77 kinase recognition site.
To characterize RNMT T77 phosphorylation, polyclonal anti-
bodies were raised against RNMT 73CGKDTPSKKR82 phos-
phorylated on T77. HA-RNMT WT or T77A were immunoprecip-
itated from cell extracts via the HA tag, and western blots were
performed to detect total RNMT and RNMT phosphorylated on
T77 (pT77) (Figure 1E, left). RNMT was detected in HA-RNMT
WT and T77A immunoprecipitates, whereas pT77 RNMT was
only detected in HA-RNMT WT immunoprecipitates. Anti-pT77
antibodies did not detect RNMT immunoprecipitated in the
absence of phosphatase inhibitors, consistent with recognition
of wild-type RNMT only when phosphorylated (Figure 1E, right).
Endogenous RNMT pT77 was also detected in anti-RNMT im-
munoprecipitates from HeLa cells (Figure 1F).
RNMT T77 Phosphorylation Is Reduced by CDK
Inhibitors
RNMT T77 is embedded in a cyclin-dependent kinase (CDK)
motif, T/S-P-x-K/R, adjacent to a cyclin recognition site, RxL
(Dinkel et al., 2011; Figure 1G). Because CDK phosphorylates
residues with proline at the +1 position, T77 could potentially
be phosphorylated by this kinase family, whereas S79 could
not (Songyang et al., 1994). We investigated whether CDK-cyclin
complexes phosphorylate RNMT T77, focusing on cell cycle and
transcription-associated kinases. RNMT T77 phosphorylation
was assessed following treatment with roscovitine, which tar-
gets CDK1, CDK2, CDK5, CDK7, and CDK9, and RO-3306,
which targets CDK1 and CDK2. Over a time course, RNMT
T77 phosphorylation was first inhibited following incubation
with 50 mM roscovitine for 10 min (Figure 1H). Across an inhib-
itor titration, inhibition of RNMT T77 phosphorylation was first
observed with 20 mM roscovitine (Figure 1I). RNMT T77 phos-
phorylation was also reduced following a 5-min incubation with
9 mM RO-3306 (Figure 1J).
Because RNMT is recruited to transcribing RNA pol II, phos-
phorylation of RNMT T77 by the RNA pol II-associated CDKs
was investigated. HeLa cells were incubated with flavopiridol
and 5,6-dichloro-1-b-D-ribofuranosylbenzimidazole (DRB), in-
hibitors whose targets include the RNA pol II CTD kinases.
Neither treatment inhibited RNMT T77 phosphorylation (Figures
1K and 1L).
RNMT T77 Is Phosphorylated during Late S and G2/M
Phases
Use of roscovitine and RO-3306 implicated CDK1 or CDK2
in RNMT T77 phosphorylation, two kinases that drive cell cycle
progression. CDK2 is predominantly active during S phase, and
CDK1 during late S and G2/M phases. We investigated whether
RNMT T77 is phosphorylated at a specific stage of the cell
cycle, consistent with either CDK1 or CDK2-dependent phos-
phorylation. HeLa cells expressing HA-RNMT were synchro-
nized at S phase entry by double thymidine block (Figure 2A,
left) or synchronized at pro-metaphase by thymidine nocoda-
zole block (Figure 2A, right). Cells were released into synchro-
nous cell cycle progression for 12 hr. To confirm cell cycle
progression, propidium iodide staining was used to determine
the proportion of cells in each phase (Figure 2A, below blots),
and extracts were analyzed for cyclin B1, E1/2, and A2 expres-
sion and histone H3 S10 phosphorylation, which oscillated
as expected (Figure 2A). Total RNMT levels were relatively
constant during the cell cycle, whereas RNMT T77 was phos-
phorylated in a cell cycle-dependent manner. Quantitation of
T77 phosphorylation in three independent experiments demon-
strated that, following double thymidine block, when cells were
predominantly in S phase, pT77 RNMT was relatively low (Fig-
ure 2A, charts at the top). After 6 hr of progression through the
cell cycle, pT77 RNMT elevated, corresponding with S phase
(F) Endogenous pT77 and total RNMT were detected in RNMT immunoprecipitates from HeLa cells.
(G) CDK and cyclin binding motifs in RNMT.
(H–L) HeLa cells expressing HA-RNMT were incubated with (H) 50 mM roscovitine, (I) a titration of roscovitine, (J) 9 mMRO-3306, (K) 1 mM flavopiridol, or (L) 50mM
DRB for the times indicated. pT77 and total RNMT were detected in HA-RNMT immunoprecipitates.
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ending and entry into G2/M phase and was lost by 12 hr,
corresponding with progression into G1 phase. Following
thymidine nocodazole block, cells were predominantly in
G2/M phase, and pT77 RNMT was elevated. On progression
through G1 phase, pT77 RNMT decreased and remained low
until 10-12 hr later, corresponding with the end of S phase
and entry into G2/M phase. In summary, RNMT T77 is initially
phosphorylated at the end of S phase and throughout G2/M
phase, and phosphorylation is gradually lost during G1 phase.
These findings were confirmed with endogenous RNMT
(Figure 2B).
RNMT T77 Is Phosphorylated by CDK1-Cyclin B1
CDK1-cyclin B1 is the predominant cyclin-dependent kinase
active during late S and G2/M phase, and therefore we investi-
gated whether it is a RNMT T77 kinase. Expression of CDK1
and cyclin B1 was repressed in cells by siRNA transfection,
with a G1 kinase, CDK3-cyclin E1, targeted as a control (Fig-
ure 3A). Transfection of CDK1 and cyclin B1 siRNA resulted in
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Figure 2. RNMT T77 Is Phosphorylated dur-
ing G2/M Phase
(A) HeLa cells expressing HA-RNMT were syn-
chronized by double thymidine or thymidine-
nocodazole block and released as indicated. In
these cells, asynchronous cells (A) and asynchro-
nous cells expressing HA-RNMT T77A (77A), WBs
were performed to detect pT77 and total RNMT
in HA-RNMT immunoprecipitates and cell cycle
markers indicated in cell extracts. Above the blots,
a chart depicts the average pT77/RNMT signal and
SD for three independent experiments, calculated
from WB using ImageJ software. Flow cytometry
cell cycle analysis and phase percentage are re-
ported below the blots.
(B) HeLa cells were synchronized, and endoge-
nous pT77 and total RNMT were detected in
RNMT immunoprecipitates.
a significant reduction in pT77, whereas
transfection of CDK3 and cyclin E1 siRNA
resulted in a minor reduction. Analysis of
cell extracts revealed that transfection of
CDK and cyclin siRNAs inhibited expres-
sion of their direct target but also inhibited
expression of each other, probably by in-
direct effects (Figure 3B). For example,
CDK1 siRNA transfection resulted in a
reduction in CDK1 and cyclin E1. How-
ever, transfection of CDK3 and cyclin E1
siRNA resulted in a similar reduction in
cyclin E1 without a significant reduction
in pT77 RNMT. Similarly, transfection
of cyclin B1 siRNA resulted in a reduc-
tion in cyclin B1 and CDK3. However, a
similar reduction in CDK3 was observed
following transfection of CDK3 and cyclin
E1 siRNA without significant loss of
pT77 RNMT. This experiment provides
evidence that CDK1-cyclin B1 is rate-limiting for pT77 phosphor-
ylation but does not prove a direct effect.
We investigated whether CDK1-cyclin B1 could phosphory-
late RNMT directly in vitro. Recombinant RNMT-RAM and
RNMT T77A-RAM were incubated with CDK1-cyclin B1 and
[g-32P] ATP and resolved by SDS-PAGE, and labeled bands
were detected by phosphoimaging (Figure 3C). RNMT was
phosphorylated by CDK1-cyclin B1 whereas RNMT T77A was
not. RNMTwas confirmed to be phosphorylated on T77 bywest-
ern blot. Phosphorylation of RAM by CDK1-cyclin B1 was not
detected (data not shown). To determine whether RNMT was
phosphorylated by CDK1-cyclin B1 with the kinetics expected
of an established substrate, the rates of phosphorylation of
RNMT and histone H1, a CDK1-cyclin B1 substrate, were
compared (Songyang et al., 1994; Figure 3D). In vitro phosphor-
ylation reactionswereperformed over a timecourse usingCDK1-
cyclin B1 and a titration of recombinant RNMT-RAM or histone
H1 (Figure S1). Reaction velocities were calculated for each
substrate concentration, allowing KM and kcat determination
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(Figure 3D). CDK1-cyclin B1 phosphorylated RNMT with a KM
of 0.71 mM and kcat of 0.93 rmol ATP/mg kinase/min and
phosphorylated histone H1 with a KM of 1.15mM and kcat of
16.33rmolATP/mgkinase/min. Therefore,CDK1-cyclinB1phos-
phorylated RNMT-RAMwith a similar KM as histoneH1. Although
the rate of phosphorylation of histone H1 is higher than that of
RNMT, histone H1 has multiple adjacent phosphorylation sites
that facilitate rapid phosphorylation, whereas RNMT has one
site (Godde and Ura, 2008).
RNMT T77 Phosphorylation Increases Cap
Methyltransferase Activity
To determine whether T77 phosphorylation alters RNMT activity,
recombinant RNMT-RAM was phosphorylated by CDK1-cyclin
B1 prior to being analyzed for cap methyltransferase activity.
Before measuring methyltransferase activity, it was important
to determine the proportion of RNMT phosphorylated during
the kinase assay. The kinase reaction was performed over a
time course, and 32P incorporation was quantitated (Figure 3E).
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Figure 3. CDK1-Cyclin B1 Phosphorylates
and Activates RNMT
HeLa cells were transfected with CDK1, CDK3,
cyclin B1, and cyclin E1 siRNA.
(A and B) After 48 hr, (A) pT77 and total RNMT
levels were analyzed in RNMT immunoprecipi-
tates, and (B) CDK and cyclin levels were analyzed
in cell extracts by WB. c, control.
(C) Recombinant His-RNMT (WT or T77A)-GST-
RAM was incubated with activated CDK1-cyclin
B1 and 32P-ATP for 60 min and resolved by SDS-
PAGE. Labeled bands were visualized by phos-
phoimaging. pT77 and total RNMTwere visualized
by WB and Coomassie stain.
(D) To assess enzyme kinetics, the CDK1-cyclin
B1 kinase reaction was performed using a titration
of RNMT or histone H1 over a time course (Fig-
ure S1). The charts depict reaction velocities for
phosphorylation of RNMT-RAM or histone H1.
Error bars represent SD for reaction velocity at
each substrate concentration. kcat and KM values
were calculated using an allosteric sigmoidal
curve fit.
(E) As in (C), except a time course experiment was
performed. Quantitation of the ATP:RNMT incor-
poration ratio is reported above.
(F) His-RNMT-GST-RAM was incubated with
activated CDK1-cyclin B1 and ATP for 10min as in
(E) and then utilized in the cap methyltransferase
assay. rxn, reaction.
(G) His-RNMT WT or 77A-GST-RAM were incu-
bated in the presence and absence of ATP and
CDK1-cyclin B1 for 10 min as above and then
utilized in the cap methyltransferase assay.
Average and SD for three independent experi-
ments is depicted. *p < 0.05 **p < 0.005, t test. See
also Figure S1.
In vitro kinase reactions are limited by
substrate inhibition and kinase half-life.
In this assay, saturation of 32P incor-
poration was reached after 40 min, and
maximal incorporation of 0.65 mol of phosphate to 1 mol of
RNMTwas achieved. Because only one CDK1-dependent phos-
phorylation site was detected on RNMT (T77) and mutation of
this site abolished 32P incorporation, it is likely that 65% RNMT
was phosphorylated once. Although 65% RNMT is phosphory-
lated in vitro, this does not reflect themaximal phosphorylation in
cells, which may be higher or lower. Following RNMT phosphor-
ylation, the cap methyltransferase assay was performed (Fig-
ure 3F). Briefly, RNMT-RAM was incubated with a guanosine-
capped transcript and the methyl donor, S-adenosyl methionine
(SAM). Following the reaction, the substrate, G(50)32ppp(50)G,
and methylated product, m7G(50)32ppp(50)G, were resolved by
thin-layer chromatography (TLC) and quantitated by phosphoi-
maging. Phosphorylated RNMT was more than 2.5-fold more
active than the unphosphorylated control (Figure 3F). These
reactions were performed following a 10-min kinase reaction
that resulted in approximately 38% RNMT phosphorylation.
Although higher levels of phosphorylation could be achieved
on longer incubation with CDK1-cyclin B1, prolonged incubation
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in kinase buffer alone resulted in a significant reduction in RNMT
cap methyltransferase activity (data not shown). To confirm that
stimulation of RNMT activity was T77 phosphorylation-depen-
dent, RNMT-RAM and RNMT T77A-RAM were incubated with
and without CDK1-cyclin B1 and ATP, and the cap methyltrans-
ferase assay was performed (Figure 3G). As observed previ-
ously, RNMT-RAM activity was increased by incubation with
CDK1-cyclin B1 and ATP but RNMT T77A-RAM activity was not.
KPNA2 RNMT Interaction Is Inhibited by RNMT T77
Phosphorylation
In addition to increasing cap methyltransferase activity, we
investigated whether T77 phosphorylation influences other as-
pects of RNMT function. We investigated whether RNMT phos-
phorylation affects interaction with RAM. However, cellular
RNMT WT and T77A were observed to interact with RAM
equivalently, and their interaction did not alter during cell cycle
progression, consistent with the observation that RAM binds to
the RNMT catalytic domain (amino acids 120–476) (Figure S2;
Gonatopoulos-Pournatzis et al., 2011). Because RNMT is re-
cruited to transcription initiation sites via the N-terminal domain,
we investigated whether this is influenced by T77 phosphoryla-
tion (Aregger and Cowling, 2013). Equivalent RNMT WT and
T77A recruitment to transcription initiation sites was observed
using a chromatin immunoprecipitation (IP) assay (Figure S3).
Because T77 lies adjacent to a nuclear localization signal
(80KKRK), we explored whether RNMT phosphorylation influ-
ences nuclear entry or retention. We visualized the nuclear
accumulation of RNMT in asynchronous cells and found that
RNMT WT, phospho-defective mutant T77A, and phospho-
mimicking mutant T77D are predominantly nuclear (representa-
tive fields in Figures S4, S5, and S6). RNMT was observed to
be excluded from chromatin during mitosis and rapidly re-enter
the reformed nucleus following mitosis. The T77A and T77D
mutations did not inhibit or enhance nuclear re-entry of RNMT
(Figures S4, S5, and S6). In summary, we did not find evidence
that T77 phosphorylation regulates RNMT interaction with
RAM, recruitment to transcription initiation sites, or nuclear entry
and retention.
To further characterize the function of T77 phosphorylation,
we investigated the cellular proteins that interact with RNMT
amino acids 57–92 using biotinylated peptides as affinity resins,
unphosphorylated (T77) and phosphorylated on T77 (pT77) (Fig-
ure 4A). Peptides were incubated in cell extracts, and interacting
proteins were purified via streptavidin pull-down. Proteins of
approximately 150 and 90 kDa were observed to bind to the
T77 peptide, and these interactions were reduced by T77
phosphorylation (Figure 4A). Several components of the nuclear
protein import machinery were found to interact specifically with
the unphosphorylated peptide. Three closely related proteins,
Importin a-1 (KPNA2), Importin a-4 (KPNA3), and Importin a-3
(KPNA4) were identified by mass spectrometry in the 90-kDa
band. Importin b-1 (KPNB1) was identified in the 150-kDa
band. KPNA2 was the most abundant Importin a subunit
identified in the T77 peptide pull-down and has been described
previously to interact with RNMT (Shafer et al., 2005; Wen and
Shatkin, 2000). Therefore, we investigated the relationship be-
tween RNMT T77 phosphorylation and the Importin a subunit,
KPNA2. Cells were transfected with pcDNA5 Myc-tagged
KPNA2 (Myc-KPNA2) or pcDNA5, and T77 and pT77 peptide
pull-downs were performed on cell extracts. Myc-KPNA2 was
observed to interact with the T77 but not the pT77 peptide (Fig-
ure 4B). In a similar assay, endogenous KPNA2 was also
observed to interact with the T77 but not the pT77 peptide (Fig-
ure 4C). The interaction between full-length RNMT and KPNA2
was investigated. In extracts of cells expressing Myc-KPNA2,
9E10 (anti-Myc) antibody IP purified Myc-KPNA2 with RNMT,
whereas a control (anti-HA) antibody was unable to immunopre-
cipitate either protein (Figure 4D). (The 9E10 antibody did not
bind to RNMT directly [Figure 5A, lane 1]). Furthermore, anti-
KPNA2 antibody IP purified endogenous KPNA2 with RNMT in
cell extracts, whereas a matched control (anti-Tubulin) antibody
did not immunoprecipitate either protein (Figure 4E). The interac-
tion between RNMT and KPNA2 was confirmed to be direct
using purified recombinant proteins. On glutathione affinity
resin, recombinant RNMT was purified with glutathione S-trans-
ferase (GST)-KPNA2 but not GST (Figure 4F), and recombinant
KPNA2 was purified with GST-RNMT but not GST (Figure 4G).
When recombinant RAM was included in these studies, it did
not bind to KPNA2 in the absence of RNMT (data not shown).
The influence of RNMT T77 phosphorylation on the interaction
with KPNA2 was investigated. HeLa cell lines were created
expressing HA-RNMT WT, T77A, T77D, and pcDNA5-Myc-
KPNA2 and vector controls. RNMT T77D was included because,
in certain contexts, aspartic acid can mimic the behavior of
phosphorylated threonine. 9E10 antibody was used to immuno-
precipitate Myc-KPNA2 with endogenous RNMT and HA-RNMT
(lanes 2–4, Figure 5A). Significantly more HA-RNMT T77A
co-purifiedwithMyc-KPNA2 than eitherWT or T77D, despite be-
ing expressed equivalently, consistent with cellular HA-RNMT
WT being phosphorylated, which reduces the interaction with
KPNA2. The fact that the T77D mutation also reduces the
interaction of RNMT with KPNA2 suggests that this mutation
functions as a ‘‘phospho-mimic.’’ Similar results were gained ad-
dressing the interaction of HA-RNMT with endogenous KPNA2
(Figure 5B). Anti-KPNA2 antibodies were used to immunoprecip-
itate KPNA2. The levels of HA-RNMT T77A immunoprecipitated
with KPNA2 were significantly higher than those of HA-RNMT
T77D and slightly higher than those of HA-RNMT WT.
Because T77 phosphorylation inhibits the interaction of
RNMT with KPNA2, the interaction of these proteins is predicted
to be low at G2/M phase when RNMT T77 phosphorylation is
high. Cells were synchronized by double thymidine block. 2 hr
(S phase) and 8 hr (G2/M phase) following release, cell extracts
were subject to immunoprecipitation (IP) with 9E10 antibody
to purify Myc-KPNA2 (Figure 5C) and with anti-KPNA2 antibody
to purify the endogenous protein (Figure 5D). As predicted, more
RNMT was immunoprecipitated with KPNA2 during S phase
than in G2/M phase. Treatment of cells with RO-3306 or rosco-
vitine, which inhibit RNMT T77 phosphorylation, increased the
interaction of RNMT with endogenous and Myc-tagged KPNA2
(Figures 5C and 5D).
KPNA2 Inhibits RNMT Activity
RNMTT77 phosphorylation increases capmethyltransferase ac-
tivity in vitro in the absence of KPNA2 (Figure 3). Because RNMT
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T77 phosphorylation regulates interaction with KPNA2, it was
relevant to determine the influence of KPNA2 on RNMT activity.
An in vitro cap methyltransferase assay was performed on re-
combinant RNMT and a titration of KPNA2. KPNA2 inhibited
cap methyltransferase activity in a dose-dependent manner
(Figure 5E). A previous publication determined the KPNA2 do-
mains that interact with RNA (amino acids 1–72) and RNMT
(amino acids 455–529) (Wen and Shatkin, 2000). Using GST-
KPNA2 pull-down, we confirmed that KPNA2 1–455 does not
interact with RNMT whereas KPNA2 72–529 does (Figure 5F).
The reciprocal interactions were also observed (Figure S7) and
confirmed in cell extracts (Figure 5G). The RNMT-binding mutant
KPNA2 1–455 did not inhibit RNMT-RAM cap methyltransferase
activity (Figure 5H). The RNA-binding mutant KPNA2 72–529
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Figure 4. RNMT T77 Phosphorylation
Inhibits Interaction with KPNA2
(A) HeLa cell extracts were incubated with bio-
tinylated-RNMT 73CGKD(T)PSKKR82 peptide,
either T77 unphosphorylated (T77) or phosphory-
lated (pT77). Peptides and associated proteins
were affinity-purified, resolved by SDS-PAGE, and
Coomassie blue-stained. Proteins in A and B were
identified by mass spectrometry. Mascot scores
are reported.
(B) HeLa cells were transfected with pcDNA5
Myc-KPNA2 or vector control, and proteins were
affinity-purified from cell extracts on RNMT pep-
tides. Myc-KPNA2 was detected by WB per-
formed using 9E10 antibody.
(C) HeLa cell extracts were affinity-purified on
RNMT peptides, and endogenous KPNA2 was
detected by WB.
(D) HeLa cells were transfected with pcDNA5Myc-
KPNA2. 9E10 antibodies were used to immuno-
precipitate Myc-KPNA2 and anti-HA antibodies
used as a control. WBs were performed to detect
Myc-KPNA2 and RNMT (adjacent panels are
components of the same blot).
(E) Anti-KPNA2 antibody was used to immuno-
precipitate KPNA2 from cell extracts, with anti-
Tubulin antibody used as a control. WBs were
performed to detect KPNA2 and RNMT. The star
indicates a non-specific band.
(F) Recombinant GST or GST-KPNA2 was incu-
bated with recombinant (untagged) RNMT and
affinity-purified on glutathione-Sepharose. Inputs
and proteins eluted were resolved by SDS-PAGE
and Coomassie blue-stained or analyzed byWB to
detect RNMT and KPNA2.
(G) As (F), except GST-RNMT was incubated with
purified recombinant KPNA2.
See also Figures S2 and S3.
also did not inhibit RNMT activity,
suggesting that KPNA2 requires both
domains to inhibit RNMT-RAM activity
(Figure 5H). Unfortunately it was not
possible to cleanly investigate the contri-
bution of KPNA2 to RNMT activity in cells
because inhibition of KPNA2 results in
loss of nuclear RNMT.
In summary, RNMT T77 phosphorylation increases the activity
of RNMT directly and indirectly by preventing the repressive
action of KPNA2. The relative contribution of these two mecha-
nisms to cellular RNMT may vary depending on the cell lineage
and physiological context.
RNMTT77 Phosphorylation Correlateswith Cellular Cap
Methyltransferase Activity
We had observed that RNMT T77 phosphorylation is elevated at
the beginning of G1 phase and falls as the cell cycle progresses
(Figure 2) and that RNMT T77 phosphorylation directly and indi-
rectly activates RNMT (Figures 3, 4, and 5). A prediction from
these observations is that cellular cap methyltransferase activity
is elevated at the initiation of G1 phase and falls during the cell
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cycle, in correlation with RNMT T77 phosphorylation. To investi-
gate the temporal nature of RNMT activity, cells were synchro-
nized at prometaphase by thymidine-nocodazole block and
released into G1 phase. At hourly intervals, nuclear extracts
were prepared in which RNMT pT77 was determined by western
blot and cap methyltransferase activity by in vitro assay (Fig-
ure 6A). At the initiation of G1 phase, RNMT pT77 levels were
relatively high and remained so until 3 hr into G1 phase. Cap
methyltransferase activity in the same extracts was also rela-
tively high at the beginning of G1 phase and remained so until
3 hr later, when activity fell 2-fold. To further probe the relation-
ship between RNMT T77 phosphorylation and cellular capmeth-
yltransferase activity during G1 phase, cells were treated with
the kinase inhibitor roscovitine for 30 min prior to lysis. Roscovi-
tine inhibited RNMT T77 phosphorylation detected 1 hr into G1
phase (Figure 6B). As observed previously, cap methyltransfer-
ase activity was relatively high 1 hr after the initiation of G1
phase, and treatment with roscovitine inhibited this activity (Fig-
ure 6B). Therefore, cellular cap methyltransferase activity corre-
lates with high RNMT T77 phosphorylation at the beginning of G1
phase.
RNMT T77 Phosphorylation and Gene Expression
The effect of RNMT T77 phosphorylation on gene expression
was examined. HA-RNMT WT and T77A were expressed in
HeLa cells for 24 hr to focus on the direct rather than indirect
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Figure 5. RNMT Phosphorylation Reduces
Inhibition by KPNA2
(A) HeLa cells expressing HA-RNMT WT, T77A,
T77D, or vector control (C) were transfected
with pcDNA5 Myc-KPNA2 or vector control (C).
9E10 antibody was used to immunoprecipitate
Myc-KPNA2, and WBs were performed to detect
HA-RNMT, RNMT, and Myc-KPNA2.
(B) KPNA2 IP was performed on HeLa cells ex-
pressing HA-RNMT WT, T77A, T77D, or a vector
control using anti-KPNA2 antibody, and KPNA2
and RNMT were detected by WB.
(C) HeLa cells were transfected with pcDNA5
Myc-KPNA2. Cells were released from double
thymidine block for 2 hr (S) or 8 hr (G2/M),
including incubation with 9 mMRO-3306 for 15min
(G2/M RO). Asynchronous cells transfected with
the vector control were used as a control. 9E10
antibody was used to immunoprecipitate Myc-
KPNA2, and WBs were performed to detect
RNMT and KPNA2.
(D) HeLa cells were treated as in (C), except that
G2/M cells were also treated with 50 mM rosco-
vitine (G2/M Rosc) for 15 min. Anti-KPNA2 anti-
bodies were used to immunoprecipitate KPNA2
from cell extracts using anti-Tubulin antibodies as
a control. WBs were performed to detect KPNA2,
RNMT, and Tubulin in extracts and immunopre-
cipitates.
(E) A cap methyltransferase assay was performed
using 40 nM recombinant RNMT and titration of
recombinant KPNA2 or BSA. Activity is reported
relative to the RNMT control.
(F) Recombinant RNMT and RAM were incu-
bated with recombinant GST-KPNA2 WT, 1–455,
72–529, or GST alone, and complexes were af-
finity-purified with glutathione-Sepharose. Inputs
and eluates were resolved by SDS-PAGE and
Coomassie blue-stained, and RAM was detected
by WB.
(G) HeLa cells were transfected with pcDNA5
Myc-KPNA2 WT, 1–455, 72–529, or vector con-
trol (C). 9E10 antibody was used to immuno-
precipitate Myc-KPNA2, and WB was performed
to detect Myc-KPNA2, KPNA2, RNMT, and
Tubulin. (Note that the KPNA2 antibody raised
against the N terminus does not recognize
KPNA2 72–529.)
(H) A cap methyltransferase assay was performed using recombinant RNMT-RAM and recombinant KPNA2 WT, 1–455, 72–529, or GST alone. The charts
depict the average and SD of four experiments. **p < 0.005, t test. Nonspecific bands are indicated with a star.
See also Figures S4, S5, S6, and S7.
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effects of inhibiting RNMT phosphorylation. Because the mRNA
cap can influence transcript expression, stability, and splicing,
extensive RNA sequencing analysis was performed. However,
no significant difference in transcript expression or splicing
was found in response to expression of RNMT T77A (data not
shown). The mRNA cap is critical for eIF4E binding and transla-
tion initiation. Therefore, we performed a proteomic analysis of
three independent HeLa whole-cell preparations expressing
RNMT WT or T77A. 4,906 proteins were identified (Table S1),
1,910 of which were detected in three independent experiments,
therefore qualifying for statistical analysis. 144 geneswere differ-
entially expressed in response to RNMT T77A (Table S2): 53
repressed in response to expression of RNMT 77A and 91 acti-
vated (t test p values < 0.05; Figure 6C; Table S2). Gene ontology
(GO) analysis for biological processes indicated a broad effect of
inhibiting RNMT T77 phosphorylation, including genes involved
in the cell cycle, apoptosis, metabolism, and RNA processing
(Table S3). GO analysis was plotted using the REVIGO suite to
reduce redundancy (Figure 6D; Supek et al., 2011).
To validate the proteomic results, the expression of four
genes, BOP1, TOMM70A, DDX18, and Skp2, was analyzed
(Table S2). In response to RNMT T77A expression, mass spec-
trometry analysis revealed that BOP1, TOMM70A, DDX18, and
Skp2 expression was significantly repressed whereas b-Tubulin
was not (Figure 6E, charts). Western blot analysis confirmed
these results (Figure 6E). Although the sequencing analysis
found that these genes were not regulated at the transcript level,
expression of RNMT T77A did reduce the proportion of BOP1,
TOMM70A, and Skp2 transcripts with an m7G cap, consistent
with a reduction of their translation and protein expression (Fig-
ure 6F). The m7G level was determined by m7G IP followed by
gene-specific RTPCR. RNMT T77A expression did not reduce
the proportion of b-Tubulin transcripts with an m7G cap or
reduce the protein level (Figures 6E and 6F). Unfortunately not
all transcripts are amenable to m7G IP, including DDX18,
possibly because of RNA secondary structure affecting anti-
m7G antibody access to the cap.
RNMT T77 Phosphorylation and Cell Proliferation
To determine the biological effect of T77 phosphorylation, the
proliferation rate of cells expressing RNMT T77A was examined.
HeLa cells were depleted of RNMT-RAM by transfection of RAM
siRNA (which depletes RNMT-RAM more efficiently than RNMT
siRNA). This resulted in a reduction in RNMT and RAM expres-
sion and a reduction in cell proliferation (Figures 7A and 7B).
HA-RNMT WT and T77A were expressed in these cells with
FLAG-RAM, resulting in equivalent expression (Figure 7A). HA-
RNMT WT but not T77A rescued the proliferation defect (Fig-
ure 7B). The effect of the T77A mutation on the ability of RNMT
to induce anchorage-independent proliferation of mammary
epithelial cells was also investigated. For this assay, RNMT-
GFP fusions were used because GFP increases RNMT expres-
sion and colony formation (Aregger and Cowling, 2013; Cowling,
2010). As observed previously, expression of RNMT-GFP results
in over 20%of mammary epithelial cells exhibiting a transformed
phenotype, forming colonies in soft agar, whereas expression of
RNMT T77A-GFP and GFP alone resulted in approximately 5%
of cells forming colonies. Therefore, in both assays, the T77A
mutation causes a defect in proliferation. In conclusion, RNMT
T77 phosphorylation is required for biologically significant gene
expression and cell proliferation.
DISCUSSION
The mRNA cap is a structure critical for gene expression, re-
cruiting complexes that mediate transcript processing and
translation initiation. We report that the mRNA cap N-7 methyl-
transferase enzymic subunit RNMT, which completes basic
cap formation, is activated by phosphorylation during G2/M
phase of the cell cycle. When transcription reinitiates after
mitosis, enhanced RNMT activity increases the rate of capping
essential to make functional mRNA.
CDK1 Activates RNMT
The predominant site of RNMT phosphorylation is amino acid
T77, which lies within the regulatory domain of the enzyme
(Aregger and Cowling, 2013). RNMT T77 phosphorylation in-
creases catalytic activity and reduces an inhibitory interaction
with KPNA2. RNMT T77 is embedded in a CDK recognition motif
adjacent to a cyclin recognition motif and is phosphorylated
during late G2/M phase until mid-G1 phase. The predominant
kinase operational during this phase is CDK1-cyclin B1, which
phosphorylates RNMT T77 directly. Other CDK-cyclin com-
plexes are operational at this phase and may also phosphorylate
RNMT. As a consequence of RNMT phosphorylation, cellular
mRNA cap methyltransferase activity is relatively high during
the first few hours of G1 phase and then drops. Inhibition of
RNMT T77 phosphorylation by use of a threonine-to-alanine
substitution results in a reduction in protein synthesis and cell
proliferation.
Because mRNA cap methylation can influence transcript
abundance, processing, and translation initiationwe investigated
the response of the proteome to inhibiting RNMT T77 phosphor-
ylation. The genes most dependent on RNMT T77 phosphoryla-
tion extendacrossmanybiological processes. Fromour analysis,
no particular gene family or gene sequence/arrangement could
be identified that favored sensitivity to RNMT phosphorylation.
It may be that a combination of chromatin context, transcrip-
tional speed, untranslated region sequence/structure, and other
factors contribute to sensitivity to RNMT phosphorylation. We
performed RNA sequencing analysis to investigate the effect
of inhibiting RNMT phosphorylation on transcript abundance
and splicing (data not shown). Despite adequate depth of
sequencing, we found no significant effect on transcript abun-
dance or splicing, suggesting that the predominant effect of the
methylation of themRNAcap inHeLa cells is translation initiation.
Function of Cell Cycle-Dependent mRNA Cap
Methylation
During mitosis, the nuclear membrane breaks down, allowing
complete division of the cellular contents. At this time, RNA pol
II and most of its associated factors detach from chromatin,
with only a few bookmarks of transcription initiation remaining
(Zaidi et al., 2010). When the nuclear membrane is reformed at
the end of M phase, RNA pol II is rapidly recruited to promoters,
accompanied by a burst of transcription and subsequent
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Figure 6. RNMT Phosphorylation Is Required for Gene Expression
(A) HeLa cells synchronized by thymidine-nocodazole block were released into G1 phase for the hours indicated. pT77 and total RNMT were detected
in RNMT immunoprecipitates by WB. Relative cap methyltransferase activity of the same cell extracts was determined. A sample result is presented,
(legend continued on next page)
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translation (Dynlacht, 1997; Pyronnet and Sonenberg, 2001).
CDK1-dependent phosphorylation of RNMT increases cap
methyltransferase activity at the initiation of G1 phase, coordi-
nating the manufacture of functional transcripts with the tran-
scriptional burst. Not only does T77 phosphorylation increase
cap methyltransferase activity, it also inhibits the negative effect
of KPNA2 on RNMT activity. This is particularly important after
completion of mitosis when the cellular pool of RNMT is being
imported into the nucleus by interaction with KPNA2 (Shafer
et al., 2005).
Although RNMT T77 phosphorylation occurs in a cell cycle-
dependent manner, its effects are independent of cell cycle
phase. Expression of RNMT T77A inhibits expression of a subset
of proteins, but these are not synthesized at a specific cell cycle
phase or check point (Stumpf et al., 2013; Tanenbaum et al.,
indicating migration of substrate, GpppG, and product, m7GpppG, on TLC. Average and SD are presented in the chart for three biologically independent
experiments.
(B) As in (A), except cells were treated with 50 mM roscovitine for 30 min prior to analyses. v, vector.
(C) Label-free proteomic analysis of HeLa cells expressing HA-RNMT WT and T77A was performed on three independent samples. Data were analyzed by
Maxquant for significance, and identified proteins are represented by volcano plot depicting the average expression ratio in cells expressing HA-RNMT 77A
versus WT.
(D) REVIGO rationalization of GO term analysis of proteins repressed in cells expressing RNMTT77A in comparisonwithWT. Axes represent semantic space used
to group GO terms of related biological processes. The color and size of each bubble indicates the p value for each GO term versus the human proteome. The
bubble size increases and color changes from red to blue with increasing p value. The proximity of the bubbles reflects the relatedness of GO terms.
(E) BOP-1, TOMM70A, DDX18, and Skp2 were detected by WB in extracts of cells expressing HA-RNMT WT, T77A, and vector control. For three independent
preparations of cells expressing HA-RNMT WT and 77A, the charts indicate the average label-free quantitation (LFQ) and SD of proteins detected in the mass
spectrometry analysis.
(F) RNA was immunoprecipitated from the same cells using an anti-m7G antibody or control, and RT-PCRwas used to detect m7G-capped transcripts relative to
total transcripts. *p > 0.05, **p > 0.001, t test.
See also Tables S1, S2, and S3.
64- 
64- 
HA
RNMT
15- 
19- 
RAM 
Tubulin 
kDa
64- 
CT7
7A
W
T
con siRNA
T7
7A
W
T
RAM siRNA
C
0 
50 
100 
150 
200 
250 
300 
1 2 3 4 
vector/con si 
RNMT WT
RNMT 77A
vector 
days 
ce
ll 
nu
m
be
r x
 1
03 RAM 
siRNA
0 
5 
10 
15 
20 
25 
30 
G
FP
R
N
M
T-G
FP
R
N
M
T T77A
-G
FP
%
 c
ol
on
ie
s 
> 
50
M
 
** ** 
G
FP
R
N
M
T-
G
FP
R
N
M
T 
T7
7A
-G
FP
RNMT-GFP
endo RNMT
64 
kDa
A B 
C D
Figure 7. RNMT T77 Phosphorylation Is
Required for Cell Proliferation
(A) HeLa cells were transfected with control or
RAM siRNA, plus pcDNA5, pcDNA5 HA-RNMT
WT, or T77A and pcDNA5 FLAG-RAM. RNMT and
RAM were detected by WB.
(B) The chart depicts average cell number and SD
for three independent experiments.
(C) Immortalized mammary epithelial cells (IMECs)
expressing pcDNA GFP, RNMT-GFP or RNMT
T77A-GFP were analyzed by WB for expression of
endogenous RNMT and RNMT-GFP.
(D) IMEC lines were plated in suspension in soft
agar. The number of established colonies (over
50 mM in diameter) after 7 days is reported. The
chart depicts the average and SD of three exper-
iments. **p < 0.005, t test.
2015). Furthermore, although preventing
RNMT phosphorylation inhibits cell pro-
liferation, the distribution of cells through
the cell cycle phases is unaffected (data
not shown). These observations may
appear contradictory. However, they are
perhaps unsurprising given that most
mammalian gene promoters contain pro-
moter-proximal paused RNA pol II, and,
therefore, capping can be uncoupled
from, and potentially occursmuch prior to, productive elongation
(Buratowski, 2009; Nilson et al., 2015; Perales and Bentley,
2009). As a result, loss of RNMT phosphorylation reduces gene
expression and cell proliferation independently of cell cycle
stage.
Regulation of mRNA Cap Methylation
The catalytic domains of mRNA cap methyltransferases are
conserved in sequence and structure in eukaryotes (Fabrega
et al., 2004). In contrast, eukaryotes vary significantly in the
sequence and length of the cap methyltransferase N-terminal
regulatory domain. The RNMT N-terminal domain has some
conservation with Vaccinia virus cap methyltransferase N-termi-
nal extension, which folds back over the SAM binding site,
occluding the ligand (De la Pen˜a et al., 2007). If RNMT has a
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similar structure, then post-translational modifications such as
T77 phosphorylation may alter the conformation of this N-termi-
nal domain, therefore altering accessibility of the SAM binding
domain. We previously established that the RNMT N-regulatory
domain influences the catalytic activity of RNMTand its promoter
recruitment (Aregger andCowling, 2013). In addition to T77phos-
phorylation, we observed that the regulatory domain is a region
of significant post-translational modifications, including phos-
phorylation, methylation, and acetylation, whereas the catalytic
domain is particularly deficient in modification (data not shown).
It seems likely that other modifications in addition to T77 phos-
phorylationwill haveglobal or gene-specific effects onproteome,
providing a route for other extra- or intracellular signaling path-
ways to coordinately regulateRNA regulons and cellular function.
EXPERIMENTAL PROCEDURES
Mass Spectrometry Analysis
50 mg cell extract was precleared for 5 hr with 50 ml murine IgG-conjugated
agarose (Sigma) and 20 ml protein A/G agarose (Santa Cruz Biotechnology).
HA-RNMT was immunoprecipitated overnight using 20 ml mouse monoclonal
anti-HA antibody-conjugated agarose (Sigma). Immunoprecipitates were
resolved SDS-PAGE and Brilliant Blue G-Colloidal-stained (Sigma). After
trypsin digestion, samples were analyzed by LC-MS/MS on a 4000 QTrap
mass spectrometer for protein identification, providing 66% coverage of
human RNMT. Precursor ion scanning followed by LC-MS/MS performed on
an LTQ Orbitrap Velos Pro mass spectrometer was used to detect phospho-
peptides. The LC-MS/MS data were used to interrogate the SwissProt or Inter-
national Protein Index (IPI) human databases using the Mascot Daemon to
identify site(s) of phosphorylation.
Cell Cycle Synchronization
For the double thymidine block, 1 3 106 cells were seeded on 10-cm plates.
2.5 mM thymidine was added for 16–18 hr. Cells were washed with PBS and
released into growth medium for 8 hr. Cells were cultured in 2.5 mM thymidine
again for 18 hr, washed, and released into growth medium.
For the thymidine-nocodazole block, 2 3 106 cells were seeded on 10-cm
plates. 2.5 mM thymidine was added for 24 hr. Cells were washed and
released into growth medium for 3 hr. 100 ng/ml nocodazole was added for
13 hr. Cells were washed and released into growth medium.
In Vitro Phosphorylation
0.33 mMHis-RNMT (WT or T77A)-GST-RAM 1–90, 0.01 mmol CDK1-Cyclin B1
(New England Biolabs), 100 mM ATP (cold or [g-32P] ATP [500 cpm/pmol])
(PerkinElmer), 10 mM MgCl2, 2 mM DTT, 50 mM Tris (pH 7.5), and 0.1 mM
EGTA were incubated in 30 ml at 30C while shaking at 1,200 rpm. Following
SDS-PAGE, RNMT bands were excised and analyzed by scintillation counter
to estimate the stoichiometry of 32P incorporation into RNMT.
Enzyme kinetics were measured using 0.01 mM CDK1-Cyclin B1 and a
titration of His-RNMT GST-RAM 1–90 or histone H1 using the previous condi-
tions. Phosphorylated protein was quantified following SDS-PAGE and autora-
diography by image densitometry. Slopes calculated from linear regression
obtained in Figure S1 were plotted as the reaction velocities in Figure 3D.
In Vitro Phosphorylation Coupled to Methyltransferase Activity
Assay
In vitro phosphorylation was performed for 10 min as above, and the reaction
was diluted inmethyltransferase (MT) buffer and subjected to capmethyltrans-
ferase assay. 330 nM RNMT-RAMwas present in the kinase assay, which was
diluted to a maximum of 30 nM in the cap methyltransferase assay.
Cap Methylation Assay
The RNA substrate was a 55-nt transcript transcribed from linearized pGEM
CE4 using T7 (Promega). 200 ng transcript was capped with 0.1 mg RNGTT,
10 mCi [a-32P]GTP (PerkinElmer), and 40 U RNasin. For the cap methylation
assay, recombinant RNMT was incubated with 2 ng substrate, 2 mMS-adeno-
syl methionine, and 10 U RNasin at 30C for 10 min. Transcripts were purified
and digested with 0.75 UP1 nuclease (Sigma) for 60min at 37C to release free
GpppG and m7GpppG. Cap structures were resolved by 0.4 M ammonium
sulfate on polyethyleneimine (PEI) cellulose plates. Labeled GpppG and
m7GpppG spots were visualized and quantified by phosphoimager.
Cap Methylation Assay Performed on Cell Extracts
106 HeLa cells were plated on a 10-cm dish. The next day, a thymidine-noco-
dazole block was performed. Following release into G1 phase, each hour cells
were lysed in Dignam A buffer, and nuclear proteins were extracted using
Dignam C buffer (Dignam et al., 1983). The buffers contained 10 mM leupeptin,
1 mMpepstatin, 10 mg/ml aprotinin, 1mMDTT, and 1:1,000 phosphatase inhib-
itor cocktail 2 and 3 (all from Sigma). The assay was performed on 3 mg nuclear
extract, as above.
Cell culture, flow cytometry, immunological methods, and protein and RNA
analyses are described in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.molcel.2016.02.008.
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